BIOMAT Database Logo BIOMAT Database Logo

[Fulminant hepatitis B as a result of reactivation in hematologic patient after chemotherapy combined with rituximab]. 2015

Purificación Cantudo-Muñoz, and María Magdalena Anguita-Arance, and Cristina Muñoz-Peña, and Carmen Amores-Antequera
Purificación Cantudo-Muñoz. Area de Microbiología. UGC Laboratorio de Análisis Clínicos. Hospital San Agustín. Avenida San Cristóbal s/n. Linares (Jaén), Spain. purificacion.cantudo.sspa@juntadeandalucia.es.

UI MeSH Term Description Entries
D008297 Male Males
D006509 Hepatitis B INFLAMMATION of the LIVER in humans caused by a member of the ORTHOHEPADNAVIRUS genus, HEPATITIS B VIRUS. It is primarily transmitted by parenteral exposure, such as transfusion of contaminated blood or blood products, but can also be transmitted via sexual or intimate personal contact. Hepatitis B Virus Infection
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000069283 Rituximab A murine-derived monoclonal antibody and ANTINEOPLASTIC AGENT that binds specifically to the CD20 ANTIGEN and is used in the treatment of LEUKEMIA; LYMPHOMA and RHEUMATOID ARTHRITIS. CD20 Antibody, Rituximab,GP2013,IDEC-C2B8,IDEC-C2B8 Antibody,Mabthera,Rituxan,IDEC C2B8,IDEC C2B8 Antibody,Rituximab CD20 Antibody
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy
D016393 Lymphoma, B-Cell A group of heterogeneous lymphoid tumors generally expressing one or more B-cell antigens or representing malignant transformations of B-lymphocytes. B-Cell Lymphoma,B Cell Lymphoma,B-Cell Lymphomas,Lymphoma, B Cell,Lymphomas, B-Cell
D058846 Antibodies, Monoclonal, Murine-Derived Antibodies obtained from a single clone of cells grown in mice or rats. Murine-Derived Monoclonal Antibodies,Antibodies, Murine-Derived Monoclonal,Monoclonal Antibodies, Murine-Derived,Murine Derived Monoclonal Antibodies
D019337 Hematologic Neoplasms Neoplasms located in the blood and blood-forming tissue (the bone marrow and lymphatic tissue). The commonest forms are the various types of LEUKEMIA, of LYMPHOMA, and of the progressive, life-threatening forms of the MYELODYSPLASTIC SYNDROMES. Blood Cancer,Hematologic Malignancies,Hematopoietic Neoplasms,Hematologic Malignancy,Hematological Malignancies,Hematological Neoplasms,Hematopoietic Malignancies,Malignancies, Hematologic,Malignancy, Hematologic,Neoplasms, Hematologic,Neoplasms, Hematopoietic,Blood Cancers,Cancer, Blood,Hematologic Neoplasm,Hematological Malignancy,Hematological Neoplasm,Hematopoietic Malignancy,Hematopoietic Neoplasm,Malignancy, Hematological,Malignancy, Hematopoietic,Neoplasm, Hematologic,Neoplasm, Hematological,Neoplasm, Hematopoietic

Related Publications

Purificación Cantudo-Muñoz, and María Magdalena Anguita-Arance, and Cristina Muñoz-Peña, and Carmen Amores-Antequera
Fulminant hepatitis B as a result of reactivation in hematologic patient after rituximab therapy.
August 2016, Journal of medical virology,
Purificación Cantudo-Muñoz, and María Magdalena Anguita-Arance, and Cristina Muñoz-Peña, and Carmen Amores-Antequera
[Fulminant hepatic failure with hepatitis B virus reactivation after rituximab treatment in a patient with resolved hepatitis B].
April 2010, The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi,
Purificación Cantudo-Muñoz, and María Magdalena Anguita-Arance, and Cristina Muñoz-Peña, and Carmen Amores-Antequera
Fulminant hepatitis subsequent to reactivation of precore mutant hepatitis B virus in a patient with lymphoma treated with chemotherapy and rituximab.
June 2003, Haematologica,
Purificación Cantudo-Muñoz, and María Magdalena Anguita-Arance, and Cristina Muñoz-Peña, and Carmen Amores-Antequera
Fulminant hepatic failure due to chemotherapy-induced hepatitis B reactivation: role of rituximab.
February 2010, Zeitschrift fur Gastroenterologie,
Purificación Cantudo-Muñoz, and María Magdalena Anguita-Arance, and Cristina Muñoz-Peña, and Carmen Amores-Antequera
Hepatitis B Virus Reactivation in a Patient with Nonalcoholic Steatohepatitis 41 Months after Rituximab-containing Chemotherapy.
February 2019, Internal medicine (Tokyo, Japan),
Purificación Cantudo-Muñoz, and María Magdalena Anguita-Arance, and Cristina Muñoz-Peña, and Carmen Amores-Antequera
Fulminant hepatitis B virus reactivation with concomitant listeriosis after fludarabine and rituximab therapy: case report.
September 2001, Annals of hematology,
Purificación Cantudo-Muñoz, and María Magdalena Anguita-Arance, and Cristina Muñoz-Peña, and Carmen Amores-Antequera
Late Hepatitis B reactivation after treatment with rituximab.
January 2022, IDCases,
Purificación Cantudo-Muñoz, and María Magdalena Anguita-Arance, and Cristina Muñoz-Peña, and Carmen Amores-Antequera
Fulminant B hepatitis in a surface antigen and hepatitis B DNA-negative patient with diffuse large B-cell lymphoma after CHOP chemotherapy plus rituximab.
February 2007, Leukemia & lymphoma,
Purificación Cantudo-Muñoz, and María Magdalena Anguita-Arance, and Cristina Muñoz-Peña, and Carmen Amores-Antequera
Hepatitis B reactivation in a patient receiving radiolabeled rituximab.
January 2005, Annals of hematology,
Purificación Cantudo-Muñoz, and María Magdalena Anguita-Arance, and Cristina Muñoz-Peña, and Carmen Amores-Antequera
Strategy for preventing hepatitis B reactivation in patients with resolved hepatitis B virus infection after rituximab-containing chemotherapy.
August 2014, Hepatology (Baltimore, Md.),
Copied contents to your clipboard!